Goodwin Procter advised Navitor Pharmaceuticals on the deal. Privately held Navitor Pharmaceuticals, LLC (“Navitor”), announced that Janssen Pharmaceuticals, Inc. (“Janssen”), one of the Janssen Pharmaceutical Companies...
You must be a Standard 1 Year member to access this content.
Baker McKenzie advised EQT on the transaction while Goodwin represented ELEVATE. EQT executed the sale of its interest in ELEVATE, a leading provider of ESG and supply...
You must be a Standard 1 Year member to access this content.
Goodwin advised The Ziegenfelder Company on the deal. The Ziegenfelder Company announced its sale to the Armstrong Group. Ziegenfelder, a manufacturer of frozen treats and the Budget...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr advised the underwriters on the deal while Goodwin Procter represented Amylyx Pharmaceuticals. Amylyx Pharmaceuticals, Inc. (“Amylyx”), a clinical-stage pharmaceutical company...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Senti Biosciences, while Davis Polk advised Dynamics Special Purpose Corp. on the deal. Senti Biosciences (“Senti Bio”) announced its definitive business combination agreement with...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised JMI Equity on the deal. JMI Equity announced its $85 million growth investment in ServiceTrade. With the additional capital, ServiceTrade will increase the pace...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Cennox on the deal. Cennox announced its acquisition of FireKing Safety and Security. The deal enables Cennox to enter the traditional and smart safe...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised EverTrue on the deal while Perkins Coie represented ThankVie. EverTrue, a leading advancement software platform, announced its merger with ThankView, the largest personalized video...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Aura Biosciences on the deal. Aura Biosciences, Inc. (Nasdaq: AURA) announced its initial public offering of 5,400,000 shares of common stock at a public...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis and Gernandt & Danielsson advised Cint Group AB on the deal, while Goodwin Procter represented Lucid Holdings, LLC. Cint Group AB (publ), a...
You must be a Standard 1 Year member to access this content.
Goodwin advised Enfusion on the deal, while Davis Polk advised the representatives of the several underwriters. Enfusion, Inc. completed its initial public offering of 21,562,500 shares...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Garuda Therapeutics on the deal. Garuda Therapeutics announced its launch and $72 million Series A financing led by Aisling Capital, Northpond Ventures, and OrbiMed,...
You must be a Standard 1 Year member to access this content.
